THTX

Theratechnologies Inc. - Common Shares (THTX)

About Theratechnologies Inc. - Common Shares (THTX)

Theratechnologies, Inc. is a pharmaceutical company, which engages in addressing medical needs of patients with Human Immunodeficiency Virus (HIV). The firm offers its product under the brand name of EGRIFTA, which is an approved therapy for the reduction of excess abdominal fat in HIV-infected patients with lipodystrophy. The company was founded on October 19, 1993 and is headquartered in Montréal, Canada.

Details

Daily high

$2.62

Daily low

$2.46

Price at open

$2.50

52 Week High

$3.13

52 Week Low

$1.12

Market cap

61.2M

Dividend yield

0.00%

Volume

179,171

Avg. volume

143,341

P/E ratio

-29.11

Theratechnologies Inc. - Common Shares News